1. Non-Surgical Treatments for Keratinocyte Carcinomas

   • Kylee J. B. Kus
   • Emily S. Ruiz

   Review 15 October 2021 Pages: 5635 - 5648

2. Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis

   • Martin Bergman
   • Namita Tundia
   • Arielle Bensimon

   Original Research Open access 12 October 2021 Pages: 5649 - 5661

   

3. Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States

   • Weiting Liao
   • Wanting Lei
   • Qiu Li

   Original Research 18 October 2021 Pages: 5662 - 5670

   

4. Selective Mediastinal Lymphadenectomy or Complete Mediastinal Lymphadenectomy for Clinical Stage I Non-Small Cell Lung Cancer: A Meta-Analysis

   • Ji Luo
   • Shize Yang
   • Siyuan Dong

   Original Research 20 October 2021 Pages: 5671 - 5683

   

5. Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia

   • Cvetka Grasic Kuhar
   • Taja Lozar
   • Maja Music Marolt

   Original Research 21 October 2021 Pages: 5684 - 5699

   

6. The Preliminary Outcome of Laser-Assisted Angioplasty Combined with Endovascular Radiofrequency Ablation for Thromboangiitis Obliterans

   • Lin Yang
   • Jingdong Tang
   • Yang Han

   Original Research 22 October 2021 Pages: 5700 - 5709

   

7. Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States

   • Ye Peng
   • Zhihua She
   • Chongqing Tan

   Original Research 24 October 2021 Pages: 5710 - 5720

   

8. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study

   • Alvin Estilo
   • Linda McCormick
   • Mirza Rahman

   Original Research Open access 25 October 2021 Pages: 5721 - 5736

   

9. Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis

   • C. Beauchemin
   • A. Castonguay
   • D. Claveau

   Original Research 26 October 2021 Pages: 5737 - 5751

   

10. Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers

    • Bryan Li
    • Thomas Yau
    • Joanne W. Chiu

    Original Research 26 October 2021 Pages: 5752 - 5762

    

11. Changes in Corneal Morphology with Age in Asian Population: A Multicenter Study of 30,618 Cases

    • Ruijue Ma
    • Yuanyuan Liu
    • Yan Wang

    Original Research Open access 10 October 2021 Pages: 5763 - 5776

    

12. Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017–2019

    • Nancy Reau
    • Mark S. Sulkowski
    • Sammy Saab

    Original Research Open access 27 October 2021 Pages: 5777 - 5790

    

13. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia

    • Ricardo Viana
    • Denise D’Alessio
    • Waleed Ghanima

    Original Research Open access 27 October 2021 Pages: 5791 - 5808

    

14. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis

    • Marjolaine Gauthier-Loiselle
    • Martin Cloutier
    • Omar Dabbous

    Original Research Open access 28 October 2021 Pages: 5809 - 5828

    

15. The Contribution of Galenics to Patients’ Sensory Perception of Nasal Sprays After Nasal Surgery: Data from a Prospective Randomised, Controlled, Double-Blind, Crossover, Multicentre Study

    • Christoph Bergmann
    • Jennifer Lander
    • Ralph Mösges

    Brief Report Open access 24 October 2021 Pages: 5829 - 5843